Nasaleze Travel contains a cellulose powder, which when inhaled into the nose forms a mucous-like gel that stops many airborne germs and viruses reaching the sensitive lining of the nose. It creates a physical barrier which shields, protects, and deactivates airborne germs and viruses that are inhaled into the nasal cavity.
Nasaleze Travel contains a cellulose powder that is inhaled into the nose. Once in the nasal cavity, the powder forms a mucous-like gel that stops many airborne germs and viruses from reaching the sensitive lining of the nose. It creates a physical barrier, providing an extra layer of protection against germs. By trapping, absorbing and neutralising airborne germs, Nasaleze Travel provides continuous protection from airborne viruses that are inhaled via the nose.
The core ingredient is Hydroxypropyl methylcellulose (HPMC) supported by odour-controlled garlic and peppermint. The powders in Nasaleze Travel have been selected to provide the optimum barrier effect with deactivating properties.
It is suitable for anyone who wants added protection from airborne germs, particularly those travelling by public transport or airplanes, as well as those working in or passing through crowded places. It can be used by pregnant and breast-feeding women, as well as children over three years old. Read product reviews here.
To defend against airborne viruses, Nasaleze Travel should be taken prior to exposure to a high virus risk environment. If travelling all day Nasaleze Travel should be applied 2 to 3 times over the course of the day.
The efficacy of the products has been demonstrated in numerous published or presented clinical trials. Read more here.
The usual dose is one puff of powder up each nostril three times a day. Each bottle contains 200 sprays, which equates to a 30 day supply. For maximum efficacy, it is necessary to maintain a constant layer of gel across the lining of the nose. It is therefore recommended that you re-administer the product after blowing your nose to renew the barrier. Click here for more guidance.
"It has been proven that Nasaleze Travel is capable of significantly reducing the production of the flu A/H5N1 virus by infected cells over a period of 72 hours from just a single daily dose. The data suggests that Nasaleze Travel could be used as a preventative measure and a treatment option for this persistent viral infection."
Dr. Peter Josling, Director and Chief Clinical Scientist of the Herbal Research Centre based in Battle